期刊文献+

老年晚发哮喘缓解期患者气道反应性和诱导痰炎性标志物的测定 被引量:2

Observation of airway hyperresponsiveness and inflammatory markers in induced sputum in elderly patients with stable late onset asthma during the remission period
原文传递
导出
摘要 目的检测缓解期老年晚发哮喘(LOA)患者气道反应性和诱导痰嗜酸细胞、嗜酸细胞阳离子蛋白(ECP)和白介素-5(IL-5)水平,探讨其临床意义。方法选择58例缓解期 LOA 患者,测定其气道反应性,并分别采用瑞氏染色、荧光免疫法和酶联免疫吸附试验检测诱导痰中嗜酸细胞数量、ECP 和 IL-5水平;选择25例急性发作期 LOA 患者和15例健康老年人作为对照。结果 58例缓解期 LOA 患者中,49例(84.5%)支气管激发试验阳性,9例(15.5%)阴性。缓解期 LOA 组诱导痰中嗜酸细胞数量[(9.3±3.1)%]、ECP[(144.2±68.1)μg/L]和 IL-5水平[(20.3±6.3)μg/L]显著低于急性发作期 LOA 组[(21.1±9.8)%、(399.3±172.5)μg/L 和(50.6±10.7)μg/L,P<0.01],但显著高于健康老年组[(1.3±0.7)%、(48.7±21.9)μg/L 和(10.3±3.2)μg/L,P<0.01]。气道反应性增高组患者诱导痰中嗜酸细胞数量[(12.7±3.6)%]、ECP[(171.3±69.8)μg/L]和 IL-5水平[(23.6±8.5)μg/L]显著高于气道反应性正常组[(3.1±1.3)%、(52.7±21.1)μg/L 和(13.7±4.1)μg/L,P<0.01]。结论缓解期 LOA 患者多数存在气道高反应性且气道炎症持续存在,测定患者气道反应性和诱导痰中炎性标志物有助于指导缓解期治疗。 Objective To investigate the clinical significance of airway hyperresponsiveness, eosinophil (Eos) percentage, levels of eosinophil cationic protein (ECP) and interleukin-5 (IL-5) in induced sputum in elderly patients with late onset asthma(LOA)during the remission period. Methods Fifty-eight elderly patients with LOA during the remission period were selected. Bronchial challenge test was performed and the percentage of Eos and levels of ECP and IL-5 in induced sputum were measured by Wrights' stain, immuno-CAP system and ELISA, respectively. Twenty-five elderly patients with LOA during their exacerbation period and 15 healthy elderly subjects were selected as control. Results In fifty-eight LOA patients during their remission period, 49 cases (84. 5%) showed positive bronchial challenge test and 9cases(15.5 %) negative. The percentage of Eos, levels of ECP and IL-5 [( 9.3 ± 3. 1 ) %], [( 144.2± 68. 1 )μg/L] and [( 20. 3 ± 6.3) μg/L, in induced sputum in patients with LOA during their remission period were lower than those[ (21.1 ± 9.8)%, (399. 3±172.5)μg/L and[ (50. 655 10. 7) μg/L, respectively]in LOA group during the exacerbation period, and higher than those[(1. 3550.7)%, (48.75:21.9) μg/L and (10.3±3.2)μg/L]in healthy group(all P〈001). The percentage of Eos, levels of ECP and IL-5 in induced sputum were all higher [(12.7±3.6)%]vs [(3.1±1.3)%]vs[(171. 3 ± 69. 8) μg/L] vs ((52. 7 ± 21.1) μg/L] and [(23. 6±8. 5) μg/L]vs[(13. 7±4. 1) μg/L] (all P〈0.01)in positive group than negative group of bronchial challenge test in LOA patients during remission period. Conclusions Airway hyperresponsiveness and persistent airway inflammation still exist in the LOA patients during the remission period and this may be a helpful guidance for treatment.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2006年第5期328-331,共4页 Chinese Journal of Geriatrics
关键词 哮喘 气道阻力 嗜酸细胞 抗微生物阳离子肽类 老年 Asthma Airway resistance Eosinophils Antimicrobial cationic peptides Sputum
  • 相关文献

参考文献10

  • 1何权瀛.老年支气管哮喘诊断治疗中的几个问题[J].中华老年医学杂志,2000,19(4):247-248. 被引量:34
  • 2National Heart,Lung,and Blood Institute.Guidelines for the diagnosis and management of asthma.National Institutes of Health,NIH Publication,1997.
  • 3British Thoracic Society.The British guidelines on asthma management.Thorax,1997,52 (Supply):S1-S21.
  • 4支气管哮喘防治指南[J].中华结核和呼吸杂志,1997,20(5):261-267. 被引量:2004
  • 5Yang J,Tu HY,Li QQ.Effect of theophylline on airway inflammation in asthma.Acta Pharmacol Sin,2001,22:475-480.
  • 6Jatakanon A,Lim S,Barnes PJ.Changes in sputum eosinophils predict loss of asthma control.Am J Respir Crit Care Med,2000,161:64-72.
  • 7聂汉祥,李长生,杨炯.诱导痰炎性标志物对老年人晚发哮喘严重程度判断和鉴别诊断的价值[J].中华老年医学杂志,2005,24(6):410-412. 被引量:4
  • 8Curre GP,Jackson CM,Lee DK.Determinants of airway hyperresponsiveness in mild asthma.Ann Allergy Asthma Immunol,2003,90:560-563.
  • 9Cass LM,Gunawardena KA,Macmahon MM.Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir.Respir Med,2000,94:166-173.
  • 10Busse W,Elias J,Sheppard D,et al.Airway remodeling and repair.Am J Respir Crit Care Med,1999,160:1035-1042.

二级参考文献9

  • 1Jatakanon A, Lim S, Barnes PJ. Changes in sputum eosinophils predict loss of asthma control. Am J Respir Crit Care Med, 2000,161: 64-72.
  • 2Pizzichini E, Pizzichini MM, Efthimiadis A, et al.Indices of airway inflammation in induced sputum:reproducibility and validity of cell fluid-phase measurements. Am J Respir Crit Care Med, 1996,154:308-317.
  • 3Fujimoto K, Kubo K, Yamamoto H, et al. Eosinophilic inflammation in the airway is related to glucocorticoid reversibility in patients with pulmonary emphysema.Chest, 1999, 115: 697-702.
  • 4Nie HX, Yang J, Hu SP, et al. Effects of theophylline on CD4^+ lymphocyte, interleukin-5, and interferon gamma in induced sputum of asthmatic subjects. Acta Pharmacol Sin, 2002,23: 267-272.
  • 5National Heart, Lung, and Blood Institute. Guidelines for the diagnosis and management of asthma. National Institutes of Health, NIH Publication, 1997.
  • 6British Thoracic Society. The British guidelines on asthma management. Thorax, 1997, 52 ( supply):S1-S24.
  • 7支气管哮喘防治指南[J].中华结核和呼吸杂志,1997,20(5):261-267. 被引量:2004
  • 8慢性阻塞性肺疾病(COPD)诊治规范(草案)[J].中华结核和呼吸杂志,1997,20(4):199-203. 被引量:1377
  • 9何权瀛.老年支气管哮喘诊断治疗中的几个问题[J].中华老年医学杂志,2000,19(4):247-248. 被引量:34

共引文献2030

同被引文献13

引证文献2

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部